Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

DiaMedica Therapeutics (DMAC) Receivables - Other (2017 - 2026)

DiaMedica Therapeutics filings provide 10 years of Receivables - Other readings, the most recent being $285000.0 for Q1 2026.

  • Quarterly Receivables - Other rose 24.45% to $285000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $285000.0 through Mar 2026, up 24.45% year-over-year, with the annual reading at $250000.0 for FY2025, 24900.0% up from the prior year.
  • Receivables - Other hit $285000.0 in Q1 2026 for DiaMedica Therapeutics, up from $250000.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $391000.0 in Q1 2024 and bottomed at $1000.0 in Q4 2024.
  • Average Receivables - Other over 5 years is $188400.0, with a median of $228000.0 recorded in 2025.
  • The largest annual shift saw Receivables - Other plummeted 99.31% in 2022 before it skyrocketed 24900.0% in 2025.
  • DiaMedica Therapeutics' Receivables - Other stood at $2000.0 in 2022, then soared by 3450.0% to $71000.0 in 2023, then tumbled by 98.59% to $1000.0 in 2024, then skyrocketed by 24900.0% to $250000.0 in 2025, then grew by 14.0% to $285000.0 in 2026.
  • Per Business Quant, the three most recent readings for DMAC's Receivables - Other are $285000.0 (Q1 2026), $250000.0 (Q4 2025), and $228000.0 (Q3 2025).